These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1804652)

  • 1. Pharmacokinetics of midazolam in children: comparative study of intranasal and intravenous administration.
    Rey E; Delaunay L; Pons G; Murat I; Richard MO; Saint-Maurice C; Olive G
    Eur J Clin Pharmacol; 1991; 41(4):355-7. PubMed ID: 1804652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers.
    Knoester PD; Jonker DM; Van Der Hoeven RT; Vermeij TA; Edelbroek PM; Brekelmans GJ; de Haan GJ
    Br J Clin Pharmacol; 2002 May; 53(5):501-7. PubMed ID: 11994056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of midazolam and alpha-hydroxy-midazolam following rectal and intravenous administration.
    Clausen TG; Wolff J; Hansen PB; Larsen F; Rasmussen SN; Dixon JS; Crevoisier C
    Br J Clin Pharmacol; 1988 Apr; 25(4):457-63. PubMed ID: 3382589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability of a novel midazolam gel after intranasal administration in dogs.
    Eagleson JS; Platt SR; Strong DL; Kent M; Freeman AC; Nghiem PP; Zheng B; White CA
    Am J Vet Res; 2012 Apr; 73(4):539-45. PubMed ID: 22452501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of midazolam after intravenous and intramuscular administration in alpacas.
    Aarnes TK; Fry PR; Hubbell JA; Bednarski RM; Lerche P; Chen W; Bei D; Liu Z; Lakritz J
    Am J Vet Res; 2013 Feb; 74(2):294-9. PubMed ID: 23363357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetic studies following intravenous and rectal administration of midazolam in children].
    Kraus GB; Gruber RG; Knoll R; Danner U
    Anaesthesist; 1989 Dec; 38(12):658-63. PubMed ID: 2619028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal midazolam in piglets: pharmacodynamics (0.2 vs 0.4 mg/kg) and pharmacokinetics (0.4 mg/kg) with bioavailability determination.
    Lacoste L; Bouquet S; Ingrand P; Caritez JC; Carretier M; Debaene B
    Lab Anim; 2000 Jan; 34(1):29-35. PubMed ID: 10759364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentrations of midazolam in children following intranasal administration.
    Walbergh EJ; Wills RJ; Eckhert J
    Anesthesiology; 1991 Feb; 74(2):233-5. PubMed ID: 1990898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of midazolam after intranasal administration.
    Burstein AH; Modica R; Hatton M; Forrest A; Gengo FM
    J Clin Pharmacol; 1997 Aug; 37(8):711-8. PubMed ID: 9378843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics of midazolam in paediatric patients.
    Payne K; Mattheyse FJ; Liebenberg D; Dawes T
    Eur J Clin Pharmacol; 1989; 37(3):267-72. PubMed ID: 2612542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and preliminary observations of behavioral changes following administration of midazolam to dogs.
    Court MH; Greenblatt DJ
    J Vet Pharmacol Ther; 1992 Dec; 15(4):343-50. PubMed ID: 1487833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics, pharmacodynamics, and safety of USL261, a midazolam formulation optimized for intranasal delivery, in a randomized study with healthy volunteers.
    Bancke LL; Dworak HA; Rodvold KA; Halvorsen MB; Gidal BE
    Epilepsia; 2015 Nov; 56(11):1723-31. PubMed ID: 26332539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacokinetic study of midazolam in dogs: nasal drop vs. atomizer administration.
    Henry RJ; Ruano N; Casto D; Wolf RH
    Pediatr Dent; 1998; 20(5):321-6. PubMed ID: 9803431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma concentrations of midazolam after i.v., nasal or rectal administration in children.
    Malinovsky JM; Lejus C; Servin F; Lepage JY; Le Normand Y; Testa S; Cozian A; Pinaud M
    Br J Anaesth; 1993 Jun; 70(6):617-20. PubMed ID: 8329252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetics of midazolam after intravenous, intramuscular, and rectal administration in healthy dogs.
    Schwartz M; Muñana KR; Nettifee-Osborne JA; Messenger KM; Papich MG
    J Vet Pharmacol Ther; 2013 Oct; 36(5):471-7. PubMed ID: 23256899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal administration of midazolam in a cyclodextrin based formulation: bioavailability and clinical evaluation in humans.
    Gudmundsdottir H; Sigurjonsdottir JF; Masson M; Fjalldal O; Stefansson E; Loftsson T
    Pharmazie; 2001 Dec; 56(12):963-6. PubMed ID: 11802661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of midazolam following intravenous and intramuscular administration to sheep.
    Simon BT; Scallan EM; O O; Ebner LS; Cerullo MN; Follette C; Cox SK; Doherty TJ; Lizarraga I
    Am J Vet Res; 2017 May; 78(5):539-549. PubMed ID: 28441044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and bioavailability of midazolam after intravenous, subcutaneous, intraperitoneal and oral administration under a chronic food-limited regimen: relating DRL performance to pharmacokinetics.
    Lau CE; Ma F; Wang Y; Smith C
    Psychopharmacology (Berl); 1996 Aug; 126(3):241-8. PubMed ID: 8876024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative pharmacokinetic study of intravenous and intramuscular midazolam in patients with epilepsy.
    Bell DM; Richards G; Dhillon S; Oxley JR; Cromarty J; Sander JW; Patsalos PN
    Epilepsy Res; 1991; 10(2-3):183-90. PubMed ID: 1817958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The single-dose pharmacokinetics of midazolam and its primary metabolite in pediatric patients after oral and intravenous administration.
    Reed MD; Rodarte A; Blumer JL; Khoo KC; Akbari B; Pou S; Pharmd ; Kearns GL;
    J Clin Pharmacol; 2001 Dec; 41(12):1359-69. PubMed ID: 11762564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.